Portfolia Direct Investment Program
Direct investments.
Since 2020, Portfolia has taken later-stage positions — through special purpose vehicles — in portfolio companies surging in growth and leading their categories. These are the proof points — and what the Portfolia Opportunity Fund thesis is built on.
Direct Investment Program Projections
Confidential. Projected exit values and multiples are Portfolia's estimates based on current valuations and company trajectory as of 6/30/26 — they are not guarantees, and actual outcomes may differ materially.
Company Profiles
The Companies in the ProgramThe largest virtual clinic for women's and family health, embedded in major US health plans. $200M → $1.7B valuation.
Clean, professional-quality hair color at home and through a growing network of Color Bar salons. Four Portfolia funds invested.
AI-driven food supply chain infrastructure connecting farms directly to grocers and restaurants. $1B → $4.5B, approaching IPO.
The wearable breast pump that redefined the category — now a full line of products for new mothers.
Developing the first non-hormonal male birth control pill, now in clinical trials.
Virtual reproductive and sexual healthcare, delivering discreet, clinician-led treatment at scale.
Advancing therapeutics for conditions long overlooked by mainstream pharmaceutical pipelines.
Clinically validated fasting-mimicking nutrition programs built on two decades of longevity research.
The fastest-growing Spanish-language streaming and advertising platform in the US. $10M → $400M valuation.
Patient-controlled health data platform, now the AI health data provider for ChatGPT, Google and Samsung. 70x from entry.
The first FDA-cleared prescription wearable to slow bone density loss from osteopenia — no drugs required.
3D-printed living sea walls that protect coastlines while restoring marine ecosystems. $18M → $70M.
Single-vesicle liquid biopsy technology built to detect ovarian and lung cancers at their earliest, most treatable stage.
RNA-based blood tests that predict pregnancy complications such as preeclampsia months before symptoms appear.
Computer vision and AI systems for heavy industry, deployed across mining, energy and logistics operations.
Biomimetic preservation technology extending the viable window for donor organs and cell therapies.
The next companies like these are coming.
These direct investments show the kind of company the Portfolia Opportunity Fund is built to back: later-stage, category-leading businesses that have already survived the hard early years.
investorrelations@portfolia.com · Accredited investors · Minimum $10,000